Abstract
BackgroundImmunogenicity influences adalimumab levels and therefore clinical response in patients with rheumatic diseases.ObjectivesTo study the relationship between clinical response, adalimumab levels and antidrug antibodies (ADAb) in ankylosing spondylitis (AS).MethodsObservational cohort...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have